We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Zhonghua Yi Xue za Zhi [Chinese medical journal] 2002 November 11
OBJECTIVE: To estimate the bystander effect mediated by herpes simplex virus-thymidine kanase/ganciclovir (HSV-TK/GCV) suicide gene therapy approach on PC-3m, a prostate cancer cell line, to explore the role of connexin (Cx) mediated gap junctional intercellular communication (GJIC) in the procedure of bystander effect of HSV-TK/GCV system and to investigate the modulation of apigenin, a Cx expression up-regulator on the connexin43 (Cx43) expression and GJIC of PC-3m cells.
METHODS: PC-3m cells were cultured and PC-3m cells transfected with EBV-based expression vector containing HSV-TK gene (TK(+) PC-3m cells) and TK(-) PC-3m cells were mixed at the ratio of 1:9. GCV was added into the mixture. The bystander effect was evaluated by MTT assay. GJIC and HSV-TK/GCV induced bystander effect in several typical cell lines, such as NIH-3T3, Cos-7, and L-02 cells, were determined by crape loading dye tracing (SLDT) and MTT assay respectively. Cx43 mRNA expression and inherent GJIC capacity of PC-3m cells were examined by RT-PCR and SLDT. TK(+) PC-3m cells and TK(-) cells were mixed and divided into 4 groups and added with GCV, apigenin, apigenin + GCV, and apigenin + GCV + 18-alpha-glycyrrhetinic acid (AGA) respectively. Then the killing rate on PC-3m cells was examined by MTT.
RESULTS: After 72 h treatment of 100 micro mol/L GCV on the mixture of wild-type PC-3m cells and HSV-TK gene modified PC-3m cells, only 23.5% +/- 3.2% cells were killed. The magnitude of HSV-TK/GCV bystander effect were more powerful in NIH-3T3, Cos-7, and L-02 cells which manifested excellent GJIC than in ACHN and HeLa cells (P < 0.001). Expression of Cx43 mRNA was shown by RT-PCR, however, it is weaker than that in ACHN cells and normal prostate tissue. With the administration of apigenin, the expression of Cx43 mRNA and the GJIC function of PC-3m cells were increased by 2.2 times (P < 0.01) The enhancing effect of apigenin on GJIC function of PC-3m cells lasted 48 hours and could be inhibited by addition of AGA. Apigenin of the concentration of 10 micro mol/L could obviously improve the bystander effect of TK system on PC-3m cells (P < 0.001). The killing rate of GCV on the mixed PC-3m cells was 59.86% +/- 2.44%, and was only 25.34% +/- 2.89% with the addition of AGA.
CONCLUSION: There is a positive correlation between the magnitude of bystander effect mediated by HSV-TK/GCV approach and the potency of internal GJIC in the target cells. Down-regulated Cx43 expression and disrupted inherent GJIC potential of PC-3m cells result in the poor magnitude of HSV-TK/GCV bystander effect. Chemical agent like apigenin up-modulates Cx43 expression and invokes GJIC capacity of PC-3m cells, thus enhancing the bystander effect and augmenting the efficacy of TK suicide therapy.
METHODS: PC-3m cells were cultured and PC-3m cells transfected with EBV-based expression vector containing HSV-TK gene (TK(+) PC-3m cells) and TK(-) PC-3m cells were mixed at the ratio of 1:9. GCV was added into the mixture. The bystander effect was evaluated by MTT assay. GJIC and HSV-TK/GCV induced bystander effect in several typical cell lines, such as NIH-3T3, Cos-7, and L-02 cells, were determined by crape loading dye tracing (SLDT) and MTT assay respectively. Cx43 mRNA expression and inherent GJIC capacity of PC-3m cells were examined by RT-PCR and SLDT. TK(+) PC-3m cells and TK(-) cells were mixed and divided into 4 groups and added with GCV, apigenin, apigenin + GCV, and apigenin + GCV + 18-alpha-glycyrrhetinic acid (AGA) respectively. Then the killing rate on PC-3m cells was examined by MTT.
RESULTS: After 72 h treatment of 100 micro mol/L GCV on the mixture of wild-type PC-3m cells and HSV-TK gene modified PC-3m cells, only 23.5% +/- 3.2% cells were killed. The magnitude of HSV-TK/GCV bystander effect were more powerful in NIH-3T3, Cos-7, and L-02 cells which manifested excellent GJIC than in ACHN and HeLa cells (P < 0.001). Expression of Cx43 mRNA was shown by RT-PCR, however, it is weaker than that in ACHN cells and normal prostate tissue. With the administration of apigenin, the expression of Cx43 mRNA and the GJIC function of PC-3m cells were increased by 2.2 times (P < 0.01) The enhancing effect of apigenin on GJIC function of PC-3m cells lasted 48 hours and could be inhibited by addition of AGA. Apigenin of the concentration of 10 micro mol/L could obviously improve the bystander effect of TK system on PC-3m cells (P < 0.001). The killing rate of GCV on the mixed PC-3m cells was 59.86% +/- 2.44%, and was only 25.34% +/- 2.89% with the addition of AGA.
CONCLUSION: There is a positive correlation between the magnitude of bystander effect mediated by HSV-TK/GCV approach and the potency of internal GJIC in the target cells. Down-regulated Cx43 expression and disrupted inherent GJIC potential of PC-3m cells result in the poor magnitude of HSV-TK/GCV bystander effect. Chemical agent like apigenin up-modulates Cx43 expression and invokes GJIC capacity of PC-3m cells, thus enhancing the bystander effect and augmenting the efficacy of TK suicide therapy.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app